Should long-acting (depot) antipsychotics be used in early schizophrenia? A systematic review.
about
Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophreniaCurrent Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive ReviewProfile of paliperidone palmitate once-monthly long-acting injectable in the management of schizophrenia: long-term safety, efficacy, and patient acceptability - a reviewPractitioner review: schizophrenia spectrum disorders and the at-risk mental state for psychosis in children and adolescents--evidence-based management approaches.The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.A qualitative study of the attitudes of patients in an early intervention service towards antipsychotic long-acting injections.Recommendations for the optimal care of patients with recent-onset psychosis in the Asia-Pacific region.Enhancing adherence, subjective well-being and quality of life in patients with schizophrenia: which role for long-acting risperidone?Treatment resistance and other complicating factors in the management of schizophrenia.Clinical benefits and impact of early use of long-acting injectable antipsychotics for schizophrenia.A further consideration on long-acting injectable versus oral antipsychotics in the treatment of schizophrenia: a narrative review and critical appraisal.Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia.Guidelines for the Pharmacotherapy of Schizophrenia in Adults."Long-acting" olanzapine in maintenance therapy of schizophrenia: A study with plasma levels.Switching to olanzapine long-acting injection from either oral olanzapine or any other antipsychotic: comparative post hoc analyses.A stitch in time: 3-monthly long-acting injectable paliperidone palmitate in schizophrenia.Discussion, debate and some areas for positive action.Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia.The Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations, Outcomes (REACH-OUT) study: real-world clinical practice in schizophrenia.Characterizing the inpatient care of young adults experiencing early psychosis: A medical record review.Combining depot antipsychotic with an assertive monitoring programme for treating first-episode schizophrenia in a resource-constrained setting.We need to talk about depot: effect of Community Treatment Order on depot antipsychotic medication compliance.
P2860
Q24597701-E897E080-2902-4D6E-8D4F-B96E72536805Q28079821-2662921F-C263-4840-B5B9-1DC0EB60FC41Q28084899-7E16443C-045C-4529-8048-914B514FBFF8Q34376032-DF2C86E6-04BF-4946-A953-5D0609132231Q34418847-EEA7ABDE-4721-413D-A709-3E2354D83A31Q34418852-AD130DEA-39D6-499E-80B6-C739B155DB5FQ35984960-AF8AA707-3194-4F9E-B1BB-9035C9B3F8A0Q36211694-75873B8A-B595-4A81-86ED-77B353BCBE99Q38269768-A1AAD72F-CDAE-481D-9C9A-CB7060E3E5BBQ38592404-5FFA9FC3-20D2-4158-B67D-981FF2AA52DEQ38659006-6A5DD373-5901-42E9-92C7-160CD28E12FEQ38851847-4119AD9E-571B-4746-8B10-4EDE882B63ECQ39432209-E6D0651C-6E60-44F8-B126-B3BE9DF9F229Q41641237-F8E482E8-C859-4973-9DAA-306202338C49Q42050098-F08D23EA-823B-45BA-B9FB-406AE6C830A7Q42361294-BE387E5A-4350-407D-A6EE-4AF83F61AD3EQ43570521-7226CB75-F556-4918-A30C-15832B0FAF12Q47154075-A4E39AAB-FC7B-4D8B-9D98-3C306674352AQ47551032-64D1519D-6D3F-4E2E-AA4B-660CF777426AQ47657498-F215317A-39A5-4596-8F10-2E77AF14EE73Q48081253-AF697177-115C-4B8E-B56C-C2F6907C3C82Q50638292-39FFEAE8-1856-47FA-B4CC-6A9FA1A8D337
P2860
Should long-acting (depot) antipsychotics be used in early schizophrenia? A systematic review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Should long-acting (depot) ant ...... ophrenia? A systematic review.
@en
type
label
Should long-acting (depot) ant ...... ophrenia? A systematic review.
@en
prefLabel
Should long-acting (depot) ant ...... ophrenia? A systematic review.
@en
P2860
P356
P1476
Should long-acting (depot) ant ...... ophrenia? A systematic review.
@en
P2093
Ka Ying Bonnie Ng
Mark Taylor
P2860
P304
P356
10.1177/0004867412470010
P577
2012-12-03T00:00:00Z